Cargando…
Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
BACKGROUND: Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are bioactive lysophospholipids involved in the pathogenesis of renal diseases, especially the renal fibrosis. Plasma LPC concentrations in chronic kidney disease (CKD) patients are lower or similar to those observed in contro...
Autores principales: | Michalczyk, Anna, Dołęgowska, Barbara, Heryć, Rafał, Chlubek, Dariusz, Safranow, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449907/ https://www.ncbi.nlm.nih.gov/pubmed/30947711 http://dx.doi.org/10.1186/s12944-019-1040-5 |
Ejemplares similares
-
Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters
por: Michalczyk, Anna, et al.
Publicado: (2017) -
Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy
por: Cecerska-Heryć, Elżbieta, et al.
Publicado: (2022) -
Effect of renal replacement therapy on selected arachidonic acid derivatives concentration
por: Cecerska-Heryć, Elżbieta, et al.
Publicado: (2020) -
Serum-to-urine renalase ratio and renalase fractional excretion in healthy adults and chronic kidney disease patients
por: Serwin, Natalia M., et al.
Publicado: (2020) -
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
por: Cecerska-Heryć, Elżbieta, et al.
Publicado: (2023)